Benzinga | Jun 7, 2021 07:11AM EDT

Lexaria Issues Progress Report on First Human Clinical Study of 2021, HYPER-H21-1



* Dosing Is Complete in First of Three Human Clinical Studies Hoped To Validate Lexaria's Patented Technology for Hypertension Relief

* Study Tested an Advanced “DehydraTECH(tm) 2.0” CBD Formulation

* Second Human Clinical Study, Hyper-H21-2, To Commence Immediately